ProShare Advisors LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$4,036,000
+70.5%
87,108
-10.3%
0.02%
+71.4%
Q1 2019$2,367,000
+76.8%
97,096
+3.3%
0.01%
+55.6%
Q4 2018$1,339,000
-21.1%
93,953
-15.8%
0.01%
-25.0%
Q3 2018$1,697,000
-12.3%
111,624
-3.3%
0.01%
-7.7%
Q2 2018$1,936,000
-2.3%
115,378
-5.0%
0.01%0.0%
Q1 2018$1,982,000
+14.1%
121,448
-10.5%
0.01%
+8.3%
Q4 2017$1,737,000
+30.2%
135,701
+25.2%
0.01%0.0%
Q3 2017$1,334,000
+54.9%
108,423
+5.3%
0.01%
+33.3%
Q2 2017$861,000
-12.1%
102,920
-6.0%
0.01%
-10.0%
Q1 2017$979,000
-19.4%
109,467
-20.8%
0.01%
-23.1%
Q4 2016$1,215,000
+70.4%
138,231
+30.8%
0.01%
+30.0%
Q3 2016$713,000
+60.9%
105,649
-15.1%
0.01%
+66.7%
Q2 2016$443,000
+21.7%
124,443
+0.9%
0.01%
+20.0%
Q1 2016$364,000
-36.3%
123,363
-8.8%
0.01%
-28.6%
Q4 2015$571,000
+2.7%
135,228
+10.9%
0.01%
-12.5%
Q3 2015$556,000
-40.9%
121,891
-6.6%
0.01%
-38.5%
Q2 2015$941,000
-8.5%
130,511
-6.5%
0.01%
+8.3%
Q1 2015$1,028,000
+90.0%
139,543
+22.0%
0.01%
+100.0%
Q4 2014$541,000
+28.5%
114,344
-3.0%
0.01%0.0%
Q3 2014$421,000
-33.0%
117,855
-14.4%
0.01%
-25.0%
Q2 2014$628,000
-39.6%
137,737
-37.7%
0.01%
-38.5%
Q1 2014$1,040,000
+227.0%
221,262
+248.4%
0.01%
+160.0%
Q4 2013$318,000
-55.5%
63,499
-44.7%
0.01%
-70.6%
Q3 2013$714,000
+60.8%
114,866
+17.4%
0.02%
+88.9%
Q2 2013$444,00097,8560.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders